Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program

LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 μM) and the PPTP in vivo panels (30 mg/kg or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice weekly. LCL161 showed a median relative IC(50) value of >10 μM, being more potent against several l...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Houghton, Peter J., Kang, Min H., Reynolds, C. Patrick, Morton, Christopher L., Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Carol, Hernan, Lock, Richard, Maris, John M., Billups, Catherine A., Smith, Malcolm A.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3253328/
https://ncbi.nlm.nih.gov/pubmed/21681929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23167
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires